|
SKAN AG / Key word(s): Annual Results SKAN announces preliminary key figures for the 2025 financial year 26-Jan-2026 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR SKAN announces preliminary key figures for the 2025 financial year Allschwil, January 26, 2026 – The SKAN Group AG, world market leader for high-quality isolator systems for aseptic production processes in the pharma and biotech industry, expects based on preliminary, not yet audited figures net sales of around CHF 332 million (2024: CHF 361.3 million) and earnings before interest, taxes, depreciation and amortization (EBITDA) of around CHF 38 million (2024: CHF 57.0 million). Order intake is expected to reach around CHF 365 million (2024: CHF 359.5 million). Publication of the 2025 financial results: SKAN Group AG will publish the detailed 2025 financial results on Tuesday, March 24, 2026, at 7:00 a.m. At the same time, the 2025 Annual Report and the 2025 year-end presentation will be available for download at www.skan.com. An investor, analyst and media conference is also planned for 10:00 a.m. at the Widder Hotel in Zurich. Further details will be provided in due course.
Contacts: Thomas Balmer, ir@skan.com, +41 79 703 87 28
Financial calendar:
SKAN – together always one step ahead
End of Inside Information |
| Language: | English |
| Company: | SKAN AG |
| Kreuzstrasse 5 | |
| 4123 Allschwil | |
| Switzerland | |
| Phone: | +41 43 268 32 32 |
| E-mail: | info@skan.com |
| ISIN: | CH0013396012 |
| Valor: | 1339601 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 2265492 |
| End of Announcement | EQS News Service |
|
|
2265492 26-Jan-2026 CET/CEST
